You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 10, October 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Randomized Controlled Trial
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
1% Pimecrolimus Cream for Atopic Dermatitis—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

I thank Dr Eichenfield and his colleagues for taking the trouble to provide the key information that was missing from their original clinical trial report.1 As an author and an editor, I fully understand and appreciate the pressures on authors to edit their reports drastically. Sometimes, however, this results in "throwing the baby out with the bathwater." Omitting to mention the fundamental aspects of a clinical trial report, such as describing how randomization was generated and hidden from the recruiting physicians,2 giving details on masking, and explaining whether ethical approval was obtained, makes it very difficult for a reader to judge the quality of the study: it is a bit like trying to buy a secondhand car without being shown the car's service history, tax disk, and road testing certificate. But now, thanks to the additional facts provided in Dr Eichenfield and colleagues' letter, it is clear to . . . [Full Text of this Article]

Hywel Williams, MSc, PhD, FRCP
Centre of Evidence-Based Dermatology
University of Nottingham
Queen's Medical Centre
Nottingham NG7 2UH, England
(e-mail: hywel.williams@nottingham.ac.uk)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.